2005 Volume 14 Issue 2 Pages 56-57
A gargling treatment by Hachiazele and Xylocaine is useful for a stomatitis treatment of the oral cancer patient with chemotherapy and/or radiotherapy. However, there is a little improvement of dry mouth. Aiming at improvement of dry mouth for the oral cancer patient with chemotherapy and/or radiotherapy, we reviewed the cevimeline hydrochloride hydrate concomitant Hachiazule and Xylocaine gargling therapeutic safety. Homeostasis for ten days of cevimeline hydrochloride hydrate was confirmed in all condition by an incompatibility examination. It was significant, and the group of cevimeline hydrochloride hydrate combination elevated salivation dosage in comparison with a non-concomitant group. In addition, the side effect did not accept both groups together. As for the cevimeline hydrochloride hydrate combination Haciazule and Xylocaine gargling treatment, it was thought that beneficial gargling was therapeutic for dry mouth of the oral cancer patient with chemotherapy and/or radiotherapy.
